PROM1 and glioblastoma: After using CBD to stimulate TRPV2 expression and activity in glioblastoma stem cells, a reduction in stem cell proliferation and self-renewal properties was detected, correlating with an increase in the terminal differentiation marker, GFAP, and a decrease in the stem cell markers CD133 and Oct-4.